Multiplex Proteomic Biomarkers in MS: Emerging Tools for Precision Care

Guest: Raphael Schneider, MD, PhD, FRCPC, CIP Multiplex proteomic biomarker panels are redefining how we understand and monitor multiple sclerosis (MS) by capturing interconnected pathways in a single sample. Hear from Dr. Raphael Schneider as he explores how these tools could inform prognosis, risk stratification, and clinical trial design, which he spoke about at the 2026 ACTRIMS Forum. Dr. Schneider is a neurologist and researcher at the BARLO MS Centre at St. Michael’s Hospital as well as an Assistant Professor and the Elizabeth S. Barford Early Career Professor in Multiple Sclerosis in the Department of Medicine at the University of Toronto.

You can listen to Multiplex Proteomic Biomarkers in MS: Emerging Tools for Precision Care online on Radio and Podcast. Open the player on this page to stream the available audio.

Multiplex Proteomic Biomarkers in MS: Emerging Tools for Precision Care is an episode from NeuroFrontiers by ReachMD.

This episode is 00:05:15 long.

This episode was published on Feb 19, 2026.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from NeuroFrontiers when more episodes are available from the podcast feed.